Nippon Shinyaku (4516) Stock Overview
Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
4516 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Nippon Shinyaku Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,999.00 |
| 52 Week High | JP¥6,529.00 |
| 52 Week Low | JP¥2,967.00 |
| Beta | -0.33 |
| 1 Month Change | -5.62% |
| 3 Month Change | -23.41% |
| 1 Year Change | 13.51% |
| 3 Year Change | -37.78% |
| 5 Year Change | -56.34% |
| Change since IPO | 277.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4516 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -1.3% | -0.5% | 4.2% |
| 1Y | 13.5% | 7.8% | 44.4% |
Return vs Industry: 4516 exceeded the JP Pharmaceuticals industry which returned 7.8% over the past year.
Return vs Market: 4516 underperformed the JP Market which returned 44.4% over the past year.
Price Volatility
| 4516 volatility | |
|---|---|
| 4516 Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in JP Market | 9.4% |
| 10% least volatile stocks in JP Market | 2.4% |
Stable Share Price: 4516 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4516's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1911 | 2,243 | Toru Nakai | www.nippon-shinyaku.co.jp |
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements.
Nippon Shinyaku Co., Ltd. Fundamentals Summary
| 4516 fundamental statistics | |
|---|---|
| Market cap | JP¥269.40b |
| Earnings (TTM) | JP¥29.72b |
| Revenue (TTM) | JP¥170.77b |
Is 4516 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4516 income statement (TTM) | |
|---|---|
| Revenue | JP¥170.77b |
| Cost of Revenue | JP¥57.46b |
| Gross Profit | JP¥113.31b |
| Other Expenses | JP¥83.59b |
| Earnings | JP¥29.72b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 440.96 |
| Gross Margin | 66.35% |
| Net Profit Margin | 17.40% |
| Debt/Equity Ratio | 0% |
How did 4516 perform over the long term?
See historical performance and comparisonDividends
Does 4516 pay a reliable dividends?
See 4516 dividend history and benchmarks| Nippon Shinyaku dividend dates | |
|---|---|
| Ex Dividend Date | Mar 30 2026 |
| Dividend Pay Date | Jun 29 2026 |
| Days until Ex dividend | 78 days |
| Days until Dividend pay date | 13 days |
Does 4516 pay a reliable dividends?
See 4516 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/16 07:39 |
| End of Day Share Price | 2026/06/16 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nippon Shinyaku Co., Ltd. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tatsuyuki Arai | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |
| Stephen Barker | CLSA |